Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Motilal Oswal S&P BSE Healthcare ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.12 |
Equity |
99.88 |
|
|
Concentration Analysis |
Top 5 Holdings |
39.75% |
Top 10 Holdings |
57.34% |
Top 25 Holdings |
78.89% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
75.34 |
Healthcare |
24.54 |
Cash |
0.12 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.36 |
PE Ratio |
35.15 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
15.10 |
Cipla Limited |
6.57 |
Max Healthcare Institute Limited |
6.53 |
DIVI LABORATORIES LTD |
5.93 |
Dr Reddys Laboratories Limited |
5.62 |
Apollo Hospitals Enterprise Limited |
5.37 |
Lupin Limited |
3.95 |
Fortis Health Care Ltd |
2.93 |
Torrent Pharmaceuticals Limited |
2.73 |
Aurobindo Pharma Limited |
2.61 |
MANKIND PHARMA LIMITED |
2.17 |
Alkem Laboratories Limited |
2.07 |
Laurus Labs Limited |
1.92 |
Glenmark Pharmaceuticals Limited |
1.86 |
Zydus Lifesciences Limited |
1.80 |
IPCA Laboratories Limited |
1.69 |
Abbott India Limited |
1.26 |
Krishna Inst of Medical Sciences Ltd. |
1.26 |
Biocon Limited |
1.22 |
Suven Pharmaceuticals Limited |
1.19 |
Syngene International Limited |
1.11 |
Piramal Pharma Limited |
1.10 |
Gland Pharma Limited |
1.01 |
Wockhardt Limited |
0.95 |
Glaxosmithkline Pharma Ltd |
0.94 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|